Ignite Creation Date:
2024-05-05 @ 10:55 PM
Last Modification Date:
2024-10-26 @ 10:26 AM
Study NCT ID:
NCT01214434
Status:
COMPLETED
Last Update Posted:
2017-03-07
First Post:
2010-09-28
Brief Title:
Promiseb Topical Cream for Cradle Cap
Sponsor:
Promius Pharma LLC
Organization:
Promius Pharma LLC
Study Overview
Official Title:
A Double Blind Placebo-Controlled Pilot Study to Estimate the Efficacy and Tolerability of Twice Daily Promiseb Topical Cream in Pediatric Subjects With Cradle Cap Seborrheic Dermatitis
Status:
COMPLETED
Status Verified Date:
2017-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the efficacy and safety of Promiseb Topical Cream in cradle cap
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None